Search PubMedSearch

Biomedical subjects

M Stano

Publications and source records attributed to M Stano.

4 recordsLinked to original sources

Further issues in small area variations analysis.

In this article, I examine Wennberg's "practice style" hypothesis and the literature on variations among small areas. According to Wennberg, geographic variations in rates of per capita use for many clinical procedures arise mainly from differences over what constitutes appropriate care. I show, however, that the role of practice style in explaining variations among areas has not been clearly demonstrated. I also argue that the practice style hypothesis can neither be established nor refuted by the methods traditionally used to study small areas and, moreover, that inferences about practice style variations cannot be drawn from differences among areas in their rates of use. I thus conclude that more research at the micro level in the practice patterns of the individual physician is needed before major health care initiatives based on small area methodology are undertaken.

Health Policy

A further analysis of the "variations in practice style" phenomenon.

To examine Wennberg's "variations in practice style" hypothesis, I examined a comprehensive data base that reflected the use of physician services in Michigan. In addition to wide variations in per capita rates of utilization across physician services markets, I found wide variations within markets in the intensity with which physicians treat their patients. I also found that within high-use markets, physicians don't treat their patients more intensively than do physicians in other markets; rather, patients are treated by a larger number of providers. Significantly, there was no relationship between variations in practice intensity within markets and per capita levels of use. I discuss the relevance of my findings for Wennberg's proposals to reduce utilization and for other health care policy issues.

Fees, Medical

Evaluation of economic effects of drug product selection legislation.

Drug product selection legislation is intended to achieve savings in the cost of prescription drugs without adversely affecting the quality of care by allowing pharmacists the opportunity to dispense less costly generically equivalent drug products in place of the product which had been prescribed by the physician. Various conditions under which the pharmacists are authorized by state laws to exercise theoption to substitute are discussed. The study then identifies and examines the conditions under which savings may and do occur, using the legislation in Michigan as the model. Over 60,000 acutal prescriptions were examined for the three-year period, April 1, 1974 through March 31, 1977--which covers the period of the year immediately before the legislation became effective and the two subsequent years-to determine: 1) the extent to which substitution is possible; 2) potential savings from generic substitution; and 3) very substantial potential cost savings from drug product selection, the actual savings represent only an extremely small proportion of the potential. This principally is due to the fact of the low rate of substitution among eligible prescriptions. Thus, if the gap between actual and potential savings is to be reduced, more attention must be given to affecting the pattern of drug selection among pharmacists.

Costs and Cost Analysis